Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice

Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice

Bibliographic Details
Main Authors: Johnson, Christopher B, Riesenberg, Brian, Neitzke, Dan, Jeng, Emily K, Marcus, Warren D, Cole, David, Wong, Hing C, Rubinstein, Mark P
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292513/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292513/

Similar Items